|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000379,
umls-concept:C0009563,
umls-concept:C0013227,
umls-concept:C0013884,
umls-concept:C0038088,
umls-concept:C0150270,
umls-concept:C0185112,
umls-concept:C0221102,
umls-concept:C0559546,
umls-concept:C0577559,
umls-concept:C0728831,
umls-concept:C1551362,
umls-concept:C1999244
|
|
pubmed:dateCreated |
2008-1-17
|
|
pubmed:abstractText |
In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg/kg treatment microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC albendazole combination was conducted in 2002.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:status |
PubMed-not-MEDLINE
|
|
pubmed:issn |
1475-2883
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
11
|
|
pubmed:dateRevised |
2010-9-16
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka.
|
|
pubmed:affiliation |
Filariasis Research Training and Service Unit, Faculty of Medicine, University of Ruhuna, Sri Lanka. miraniweera@yahoo.co.uk
|
|
pubmed:publicationType |
Journal Article
|
